Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1983-10-07
1985-12-17
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 564 20, A61K 4900, A61K 4300
Patent
active
045592217
ABSTRACT:
A radioactive diagnostic agent which comprises a physiologically active substance and a radioactive metallic element combined with a compound of the formula: ##STR1## wherein R is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group and n is an integer of 0 to 4. The agent is characteristic in having a high stability even after being administered into a human body and showing the substantially the same behavior as the physiologically active substance itself in a human body.
REFERENCES:
patent: 3382275 (1968-05-01), Barrett
patent: 3709935 (1973-01-01), Barrett
patent: 3824276 (1974-07-01), Murray et al.
patent: 4287362 (1981-09-01), Yokoyama et al.
patent: 4338248 (1982-07-01), Yokoyama et al.
Japanese Journal of Nuclear Medicine, vol. 19, No. 9, p. 1336, issued Oct. 20, 1982 (with translation).
Yokoyama et al, Chem. Abstracts, 101, (1984), #35249u.
Yokoyama et al, Chem. Abstracts, 85, (1976), #139238g.
Arano Yasushi
Magata Yasuhiro
Yokoyama Akira
Nihon Medi+Physics Co., Ltd.
Nucker Christine M.
LandOfFree
P-Glyoxyloylphenylalkanoic acid bis(thiosemicarbazone) derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P-Glyoxyloylphenylalkanoic acid bis(thiosemicarbazone) derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P-Glyoxyloylphenylalkanoic acid bis(thiosemicarbazone) derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2174192